Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 3/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 2/20 | 0.44 |
| ▸ | AR | P10275 | 2/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.44 |
| ▸ | BAX | Q07812 | 1/20 | 0.44 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2485652 | 0.94 | MEN1 (0.56) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL13011575 | 0.91 | TEAD4 (0.50) | MEN1KMT2AACHEARTEAD4 | |
| SCHEMBL465518 | 0.89 | MEN1 (0.48) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL10749041 | 0.85 | ESR1 (0.52) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL825065 | 0.85 | ESR1 (0.52) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL28091759 | 0.84 | ESR2 (0.46) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL10035481 | 0.82 | MEN1 (0.74) | MEN1KMT2AESR1ESR2LTA4H | |
| Hydroquinone SCHEMBL10909082 | 0.82 | MEN1 (0.74) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL3002512 | 0.82 | MEN1 (0.74) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL1101891 | 0.82 | MEN1 (0.74) | MEN1KMT2AESR1ESR2LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10766887-B2 | Benzoxazine-based mixture and use thereof | KOLON INDUSTRIES, INC. (KR) | 2020-09-08 | — | — | US | disclosed |
| US-20190169177-A1 | BENZOXAZINE-BASED MIXTURE AND USE THEREOF | KOLON INDUSTRIES, INC. (KR) | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169177-A1 | BENZOXAZINE-BASED MIXTURE AND USE THEREOF | HELZ, GABBR1, CBX7 | MEN1 3688/4885KMT2A 230/4885ESR1 535/4885 |
| US-10766887-B2 | Benzoxazine-based mixture and use thereof | HELZ, GABBR1, CBX7 | MEN1 3688/4885KMT2A 230/4885ESR1 535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.